Lapatinib ditosylate
Lapatinib ditosylate | |
---|---|
Term | Lapatinib ditosylate |
Short definition | lapatinib ditosylate (luh-PA-tih-nib dy-TOH-sih-layt) A drug used with capecitabine or letrozole to treat certain types of HER2-positive breast cancer that have progressed are or have spread. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
lapatinib ditosylate - (pronounced) (luh-PA-tih-nib dy-TOH-sih-layt) A drug used with capecitabine or letrozole to treat certain types of HER2-positive breast cancer that have progressed are or have spread. It is also being studied in the treatment of other types of cancer. Lapatinib ditosylate blocks EGFR and other proteins that may help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Lapatinib is the active ingredient in lapatinib ditosylate. Also called GW572016 and Tykerb
External links
- Medical encyclopedia article on Lapatinib ditosylate
- Wikipedia's article - Lapatinib ditosylate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski